Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab + Methotrexate in Moderate to Severe RA
NCT00754572Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2009
- Primary completion
- Oct 2012
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 10
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Feb 2009; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00754572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754572.